HDAC6 and Parkinson disease: Venlafaxine, an antidepressant, has HDAC6-inhibiting properties, and inhibition of striatal HDAC6 increases the autophagic clearance of α-syn, restores the lost striatal dopamine levels and preserves dopaminergic neurons in a rotenone-induced rat PD model.